Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2017-12-04
Original SEC Filing: Click here

---

Webplus: BSPM/20171204/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Regains Compliance with NASDAQ Continued Listing Requirement XIANYANG, China, December 4, 2017 /PRNewswire/ – Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) (“Biostar” or “the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced that on November 30, 2017, it received a letter from the NASDAQ Listing Qualifications Staff (“Staff”) notifying the Company that it regained compliance

---

---

Webplus: BSPM/20171204/8-K/1/000.htm SEC Original: biostar8k120417.htm
FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ☐ ☐ ☐ ☐ ☐ Emerging

---

Company Info:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2017-12-04CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046